Related Experiment Video
Updated: May 17, 2026

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
Published on: May 10, 2022
Pathogenesis of hepatitis B virus infection and potential for new therapies
1University College London, London, UK. d.peppa@ucl.ac.uk
Abstract:
Chronic hepatitis B virus infection leads to about 1 million deaths per year, making it one of the top ten causes of death worldwide. An improved understanding of defective antiviral responses in chronic hepatitis B virus infection could allow specific immunotherapeutic interventions, enhancing the immune response to hepatitis B virus.
Related Concept Videos
Hepatitis
Viral Hepatitis I: Introduction
Inhibitors of Viral Protein Synthesis
Microorganisms in Medicine and Therapeutics
Viruses with RNA Genomes
Cirrhosis II: Pathophysiology

